Journal: NAR Cancer
Article Title: Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology
doi: 10.1093/narcan/zcac033
Figure Lengend Snippet: PANoptosis has a prognostic impact in cancers. ( A ) Consensus Clustering showing three distinct clusters (PANoptosis low, PANoptosis medium and PANoptosis high) based on PANoptosis gene expression for SKCM. ( B ) Heatmap depicting gene expression profiles of 27 PANoptosis markers including sensors and upstream regulators, adaptors and effectors of PANoptosis as scaled Z-scores for SKCM tumor samples. For brevity, 13 out of the 27 genes are labeled, but 27 distinct rows are shown. ( C ) Boxplot showing the distribution of PANoptosis scores in the three PANoptosis clusters for cancer subtypes of interest: LGG, KIRC and SKCM. ( D ) Forest plot showing N1 = number of samples in PANoptosis high cluster, N2 = number of samples in PANoptosis low cluster, P -value and hazard ratio (HR) with 95% CI for overall survival (OS) when comparing PANoptosis high versus low for each cancer type where there is significant prognostic impact ( P -value < 0.05). ( E–G ) Kaplan–Meier curves showing OS across the PANoptosis high and PANoptosis low groups in the three cancer types with significant differences in survival (PANoptosis high beneficial [HR < 1] or detrimental [HR > 1]). *** P -value < 0.001.
Article Snippet: Single cell transcriptomics datasets for LGG and SKCM cancer types were downloaded from the Broad Institute Single Cell Portal under accession number SCP271 ( ) and GEO Accession viewer under accession ID GSE72056 , respectively.
Techniques: Gene Expression, Labeling